MyFibroScan

Android App Analysis And Review: MyFibroScan, Desenvolvido Por Liver-IT. Listado Na Categoria Saúde E Fitness. A Versão Atual É 2.4.0, Atualizada Em 28/10/2024 . De Acordo Com Os Usuários, Avaliações No Google Play: MyFibroScan. Alcançados Sobre Instalações 18 Mil. Atualmente, O MyFibroScan Tem 44 Críticas, Classificação Média De 2.8 Estrelas

fibroscan® is the non-invasive solution for comprehensive management of liver health.

fibroscan® provides unique and patented biomarkers, lsm by vcte™ (liver stiffness measurement) and cap™ (controlled attenuation parameter) that benefit from a worldwide clinical evidence with over 2500 peer-reviewed publications and 60+ international guidelines.

myfibroscan app is your everyday fibroscan® companion to access interpretation guide and fibroscan® based scores in an easy, fast and intuitive way :{# }
the interpretation guide utilizes data from clinical studies to assist providers in interpreting fibroscan® examination results.
scores enhance fibroscan® liver disease assessment with biological markers.
scores are presented as educational services intended for licensed healthcare professionals . while the scores are about specific medical and healthcare issues, they are not a substitute for/or replacement of personalized medical advice and are not intended to be used as the sole basis for making individualized medical or health-related decisions.

- agile™3+ is an aid to identify nafld patients with advanced fibrosis by combining vcte™ and routine clinical parameters to reduce the need for liver biopsy. high clinical performances are demonstrated in large external validation cohorts from different geographical origins.

- agile™4 is an aid to early identify nafld patients with cirrhosis by combining vcte™ and routine clinical parameters. it can help the physicians to manage the disease to prevent liver-related complications such as hepatocellular carcinoma. high clinical performances are demonstrated in large external validation cohorts from different geographical origin.

- fast™ is an aid to identify at risk nash patients defined as nash + nas≥4 + f≥2. good to excellent performance in cohorts from different clinical settings (nafld tertiary care unit, screening, bariatric surgery) and geographical origins (usa, europe, asia). several publications advocate the use of fast™.

Read more